Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of beta-blockers and antiplatelet regimens in spontaneous coronary artery dissection
2021-001905-66Phase 4Active
- Sponsor
- Sociedad Española de Cardiología
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of carvedilol in spontaneous coronary artery dissection (SCAD) (3 arms), sponsored by Sociedad Española de Cardiología. Primary endpoint: Primary composite cardiovascular endpoint. Started Jun 2021; status: active.
02
Drugs
carvedilol
03
Conditions
spontaneous coronary artery dissection (SCAD)
Beyond the preview
Go deeper on 2021-001905-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001905-66.